Faculty Disclosures

Article Outline

 

The authors who contributed to this publication have disclosed the following industry relationships.

Lawrence V. Friedrich, PharmD, is an employee and a stockholder of Cubist Pharmaceuticals, Inc.

Yoav Golan, MD, MS, is a member of the Speakers’ Bureau for Cubist Pharmaceuticals, Inc., Merck & Co., Inc., Schering-Plough Corporation, and Wyeth; and has received research/grant support from Cubist Pharmaceuticals, Inc., Merck & Co., Inc., and Wyeth.

Kenneth C. Lamp, PharmD, is an employee and a stockholder of Cubist Pharmaceuticals, Inc.

Donald P. Levine, MD, is a member of the Speakers’ Bureau for Cubist Pharmaceuticals, Inc.; serves as a consultant to Cubist Pharmaceuticals, Inc., and Astellas Pharma Inc.; and has received research/grant support from Cubist Pharmaceuticals, Inc.

Luke Mendez-Vigo, PharmD, is an employee of Cubist Pharmaceuticals, Inc.

Robert C. Owens, Jr., PharmD, has no financial arrangement or affiliation with a corporate organization or a manufacturer of a product discussed in this supplement.

Kenneth V.I. Rolston, MD, is a member of the Speakers’ Bureau for Cubist Pharmaceuticals, Inc., serves as a consultant to Cubist Pharmaceuticals, Inc., and has received research grant support from Cubist Pharmaceuticals, Inc.

Rene Russo, PharmD, is an employee and a stockholder of Cubist Pharmaceuticals, Inc.

George Sakoulas, MD, is a member of the Speakers’ Bureau for Cubist Pharmaceuticals, Inc., Pfizer Inc, Merck & Co., Inc., and Wyeth; serves as a consultant to Cubist Pharmaceuticals, Inc. and Pfizer Inc; and has received research/grant support from Cubist Pharmaceuticals, Inc. and Pfizer Inc.

John Segreti, MD, is a member of the Speakers’ Bureau for Cubist Pharmaceuticals, Inc., Ortho-McNeil, Inc., Pfizer Inc, and Wyeth; serves as a consultant to Cubist Pharmaceuticals, Inc.; and has received research/grant support from Cubist Pharmaceuticals, Inc.